NNO2

VIE · Equity

Novo Nordisk A/S

AT Healthcare Drug Manufacturers - General

Latest week
29 May 2026
Close
39.134998
Fair value
49.004792
Expectation
Undecided 54.91%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
39.13
12-Week Change
57.47%
Trend Signal
Active
Expectation
Undecided 54.91%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-8.29
Market Dynamics
1.34

Over the latest 12 completed weeks ending 2026-05-29, NNO2 rose 57.47%, moving from 24.85 to 39.13. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is -8.29 and has improved across the 12-week window. Market Dynamics is 1.34 on the latest week. Expectation is undecided at 54.91%.